CLINICAL TRIAL / NCT05791201

A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes

  • Interventional
  • Recruiting
  • NCT05791201

A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-264 in Subjects With Type 1 Diabetes Mellitus

The purpose of the study is to evaluate the safety, tolerability, and efficacy of VX-264 in participants with type 1 diabetes (T1D).